Wang James Jiqi, Yu Bo, Li Zongzhe
Division of Cardiology, Departments of Internal Medicine and Genetic Diagnosis Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, People's Republic of China.
Hubei Key Laboratory of Genetics and Molecular Mechanisms of Cardiological Disorders, Huazhong University of Science and Technology, Wuhan, China.
BMC Med Genet. 2019 May 27;20(1):91. doi: 10.1186/s12881-019-0828-5.
Hereditary sensory and autonomic neuropathy (HSAN) type II is a group of extremely rare autosomal recessive neurological disorders with heterogeneous clinical and genetic characteristics.
We performed high-depth next-generation targeted sequencing using a custom-ordered "HSAN" panel, covering WNK1, NTRK1, NGF, SPTLC1 and IKBKAP genes, to identify pathogenic variants of the proband as well as the family members. We also performed whole exome sequencing to further investigate the potential occurrence of additional pathogenic variants in genes that were not covered by the "HSAN" panel. Quantitative real-time PCR was used to identify pathogenic copy number variations (CNVs) and to analyze the mRNA level of WNK1 gene of the family. Western blot analysis was performed to evaluate the WNK1 protein expression level.
After sequencing, a novel nonsense variant (c.2747 T > G, p.Leu916Ter) in exon 9 of WNK1 gene was identified in two patients (hemizygous) and their mother (heterozygous). This variant is absent in all public databases as well as in 600 Han Chinese healthy controls. The region of this variant is evolutionary highly conserved. Furthermore, by quantitative real-time PCR using DNA of the pedigree, we revealed a large deletion containing the whole WNK1 gene in two patients. The WNK1 expression levels of the patients were significantly reduced.
Our study firstly revealed that the coexistence of a novel WNK1 nonsense variant and a CNV resulted in HSAN type IIA in a Han Chinese family.
遗传性感觉和自主神经病变(HSAN)II型是一组极为罕见的常染色体隐性神经疾病,具有异质性的临床和遗传特征。
我们使用定制的“HSAN”基因 panel 进行了高深度下一代靶向测序,该 panel 涵盖了WNK1、NTRK1、NGF、SPTLC1和IKBKAP基因,以鉴定先证者及其家庭成员的致病变异。我们还进行了全外显子组测序,以进一步研究“HSAN”基因 panel 未涵盖的基因中潜在的其他致病变异的发生情况。定量实时PCR用于鉴定致病性拷贝数变异(CNV)并分析该家族WNK1基因的mRNA水平。进行蛋白质免疫印迹分析以评估WNK1蛋白表达水平。
测序后,在两名患者(半合子)及其母亲(杂合子)中鉴定出WNK1基因第9外显子中的一个新的无义变异(c.2747 T > G,p.Leu916Ter)。该变异在所有公共数据库以及600名汉族健康对照中均不存在。该变异区域在进化上高度保守。此外,通过使用该家系的DNA进行定量实时PCR,我们在两名患者中发现了一个包含整个WNK1基因的大片段缺失。患者的WNK1表达水平显著降低。
我们的研究首次揭示了一个新的WNK1无义变异与一个CNV共存导致一个汉族家庭患HSAN IIA型疾病。